,pembrolizumabamrubicin:

Kazutaka Mitani1, Ichiro Tsuboi1, Gen Tanaka1

  • 1Department of Urology Shimane University Faculty of Medicine Izumo Shimane Japan.

IJU case reports
|March 5, 2024
PubMed
概括

阿姆鲁比作为高级小细胞膀癌的第三线治疗方法具有前景,在患有转移性多叶膜干扰的患者中实现稳定疾病. 这为这种罕见而有侵略性的癌症提供了潜在的新选择.